$CPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATALYST PHARMACEUTICALS, INC.. Get notifications about new insider transactions in CATALYST PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Financial Off ... | Option Exercise | M | 0.47 | 200,000 | 94,000 | 270,000 | |
Nov 07 2017 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | Chief Financial Off ... | Buy | M | 0.47 | 200,000 | 94,000 | 396,346 | 196.3 K to 396.3 K (+101.86 %) |
Sep 05 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.58 | 20,000 | 51,560 | 4,471,026 | 4.5 M to 4.5 M (+0.45 %) |
May 22 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | X | 1.04 | 31,250 | 32,500 | 0 | |
May 22 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 1.04 | 31,250 | 32,500 | 4,451,026 | 4.4 M to 4.5 M (+0.71 %) |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 250,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 220,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 250,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 220,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 1.13 | 50,000 | 56,500 | 785,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 1.13 | 50,000 | 56,500 | 735,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 1.13 | 50,000 | 56,500 | 685,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 1.13 | 83,334 | 94,167 | 1,250,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 1.13 | 83,333 | 94,166 | 1,166,666 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 1.13 | 83,333 | 94,166 | 1,083,333 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 1.13 | 50,000 | 56,500 | 550,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 1.13 | 50,000 | 56,500 | 500,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 1.13 | 50,000 | 56,500 | 450,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 1.13 | 50,000 | 56,500 | 770,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 1.13 | 50,000 | 56,500 | 720,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 1.13 | 50,000 | 56,500 | 670,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 200,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 170,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 200,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 170,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 250,000 | |
Jan 05 2017 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 1.13 | 30,000 | 33,900 | 220,000 | |
Nov 18 2016 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 0.00 | 26,667 | 0 | 26,667 | |
Nov 18 2016 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 0.00 | 26,667 | 0 | 4,419,776 | 4.4 M to 4.4 M (+0.61 %) |
Jul 12 2016 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 0.81 | 20,000 | 16,272 | 432,126 | 412.1 K to 432.1 K (+4.85 %) |
Jun 20 2016 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 0.76 | 13,300 | 10,108 | 173,287 | 160 K to 173.3 K (+8.31 %) |
Jun 20 2016 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 0.75 | 1,700 | 1,275 | 159,987 | 158.3 K to 160 K (+1.07 %) |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 220,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 195,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 220,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 195,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 0.79 | 50,000 | 39,500 | 725,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 0.79 | 50,000 | 39,500 | 675,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.79 | 100,000 | 79,000 | 1,100,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.79 | 100,000 | 79,000 | 1,000,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 0.79 | 50,000 | 39,500 | 400,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 0.79 | 50,000 | 39,500 | 350,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 0.79 | 50,000 | 39,500 | 710,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 0.79 | 50,000 | 39,500 | 660,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 140,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 115,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 140,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 115,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 215,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 190,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 215,000 | |
Jun 17 2016 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 0.79 | 25,000 | 19,750 | 190,000 | |
Jun 14 2016 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | P | 0.65 | 50,000 | 32,500 | 100,000 | 50 K to 100 K (+100.00 %) |
Jun 14 2016 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.65 | 105,300 | 68,529 | 4,393,109 | 4.3 M to 4.4 M (+2.46 %) |
Apr 27 2016 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 0.60 | 20,000 | 11,920 | 412,126 | 392.1 K to 412.1 K (+5.10 %) |
Apr 26 2016 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 0.65 | 50,000 | 32,430 | 4,287,809 | 4.2 M to 4.3 M (+1.18 %) |
Mar 17 2016 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | P | 1.06 | 10,000 | 10,600 | 158,287 | 148.3 K to 158.3 K (+6.74 %) |
Mar 16 2016 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 1.11 | 10,000 | 11,062 | 392,126 | 382.1 K to 392.1 K (+2.62 %) |
Feb 01 2016 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 1.87 | 5,000 | 9,325 | 382,126 | 377.1 K to 382.1 K (+1.33 %) |
Jan 12 2016 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Buy | P | 1.80 | 7,933 | 14,279 | 457,687 | 449.8 K to 457.7 K (+1.76 %) |
Jan 11 2016 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 1.94 | 5,000 | 9,685 | 377,126 | 372.1 K to 377.1 K (+1.34 %) |
Jan 07 2016 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | P | 2.03 | 25,000 | 50,750 | 50,000 | 25 K to 50 K (+100.00 %) |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 90,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Daly Richard J | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 70,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 165,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 145,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 170,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 150,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 170,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 150,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 625,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 575,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 525,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Merrigan Paul J | Chief Commercial Of ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 300,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Merrigan Paul J | Chief Commercial Of ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 250,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | Merrigan Paul J | Chief Commercial Of ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 200,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 2.53 | 100,000 | 253,000 | 900,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 2.53 | 100,000 | 253,000 | 800,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 2.53 | 100,000 | 253,000 | 700,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 300,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 250,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | INGENITO GARY | Chief Medical Offic ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 200,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 610,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 560,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | A | 2.53 | 50,000 | 126,500 | 510,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 90,000 | |
Jan 04 2016 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Option Exercise | A | 2.53 | 20,000 | 50,600 | 70,000 | |
Dec 28 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.39 | 25,000 | 59,725 | 4,237,809 | 4.2 M to 4.2 M (+0.59 %) |
Dec 23 2015 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.41 | 5,000 | 12,044 | 372,126 | 367.1 K to 372.1 K (+1.36 %) |
Dec 07 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 0.00 | 26,666 | 0 | 53,334 | |
Dec 07 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 0.00 | 26,666 | 0 | 4,212,809 | 4.2 M to 4.2 M (+0.64 %) |
Nov 19 2015 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.30 | 5,000 | 11,482 | 367,126 | 362.1 K to 367.1 K (+1.38 %) |
Nov 05 2015 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | M | 1.09 | 60,000 | 65,400 | 237,500 | |
Nov 05 2015 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Sell | M | 1.09 | 60,000 | 65,400 | 134,131 | 194.1 K to 134.1 K (-30.91 %) |
Oct 30 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 1.09 | 75,000 | 81,750 | 600,000 | |
Oct 30 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Payment of Exercise | F | 0.00 | 26,119 | 0 | 4,186,143 | 4.2 M to 4.2 M (-0.62 %) |
Oct 30 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 1.09 | 75,000 | 81,750 | 4,212,262 | 4.1 M to 4.2 M (+1.81 %) |
Oct 29 2015 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | M | 1.09 | 30,000 | 32,700 | 105,000 | |
Oct 29 2015 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Payment of Exercise | F | 0.00 | 10,000 | 0 | 263,401 | 273.4 K to 263.4 K (-3.66 %) |
Oct 29 2015 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Buy | M | 1.09 | 30,000 | 32,700 | 273,401 | 243.4 K to 273.4 K (+12.33 %) |
Oct 23 2015 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Sell | S | 3.34 | 22,800 | 76,152 | 74,131 | 96.9 K to 74.1 K (-23.52 %) |
Oct 01 2015 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 2.85 | 10,000 | 28,500 | 362,126 | 352.1 K to 362.1 K (+2.84 %) |
Oct 01 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.81 | 10,000 | 28,100 | 4,137,262 | 4.1 M to 4.1 M (+0.24 %) |
Aug 27 2015 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | M | 1.09 | 60,000 | 65,400 | 475,000 | |
Aug 27 2015 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Buy | M | 1.09 | 60,000 | 65,400 | 449,754 | 389.8 K to 449.8 K (+15.39 %) |
Aug 26 2015 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | M | 1.09 | 40,000 | 43,600 | 460,000 | |
Aug 26 2015 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Buy | M | 1.09 | 40,000 | 43,600 | 196,346 | 156.3 K to 196.3 K (+25.58 %) |
Aug 26 2015 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | M | 1.09 | 30,000 | 32,700 | 130,000 | |
Aug 26 2015 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | M | 1.09 | 30,000 | 32,700 | 352,126 | 322.1 K to 352.1 K (+9.31 %) |
Aug 26 2015 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | M | 1.09 | 25,000 | 27,250 | 125,000 | |
Aug 26 2015 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Payment of Exercise | F | 0.00 | 8,385 | 0 | 148,287 | 156.7 K to 148.3 K (-5.35 %) |
Aug 26 2015 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | M | 1.09 | 16,615 | 18,110 | 156,672 | 140.1 K to 156.7 K (+11.86 %) |
May 01 2015 | CPRX | CATALYST PHARMACEU ... | MUTH DAVID D | EVP, Chief Commerci ... | Buy | P | 3.20 | 1,700 | 5,440 | 44,700 | 43 K to 44.7 K (+3.95 %) |
Apr 30 2015 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | P | 3.25 | 5,000 | 16,250 | 25,000 | 20 K to 25 K (+25.00 %) |
Apr 30 2015 | CPRX | CATALYST PHARMACEU ... | MUTH DAVID D | EVP, Chief Commerci ... | Buy | P | 3.55 | 300 | 1,065 | 43,000 | 42.7 K to 43 K (+0.70 %) |
Apr 30 2015 | CPRX | CATALYST PHARMACEU ... | MUTH DAVID D | EVP, Chief Commerci ... | Buy | P | 3.55 | 1,700 | 6,033 | 42,700 | 41 K to 42.7 K (+4.15 %) |
Apr 30 2015 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 3.29 | 10,000 | 32,940 | 322,126 | 312.1 K to 322.1 K (+3.20 %) |
Apr 28 2015 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | P | 3.71 | 15,000 | 55,650 | 20,000 | 5 K to 20 K (+300.00 %) |
Apr 27 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 3.79 | 5,000 | 18,950 | 4,127,262 | 4.1 M to 4.1 M (+0.12 %) |
Apr 24 2015 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 3.80 | 5,000 | 19,000 | 312,126 | 307.1 K to 312.1 K (+1.63 %) |
Mar 30 2015 | CPRX | CATALYST PHARMACEU ... | DENKHAUS DONALD A | Director | Buy | P | 4.17 | 5,000 | 20,850 | 5,000 | 0 to 5 K |
Feb 27 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 0.69 | 364,804 | 249,891 | 786,250 | |
Feb 27 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Payment of Exercise | F | 0.00 | 67,539 | 0 | 4,122,262 | 4.2 M to 4.1 M (-1.61 %) |
Feb 27 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 0.69 | 364,804 | 249,891 | 4,189,801 | 3.8 M to 4.2 M (+9.54 %) |
Jan 22 2015 | CPRX | CATALYST PHARMACEU ... | MUTH DAVID D | EVP, Chief Commerci ... | Buy | P | 2.96 | 21,000 | 62,074 | 41,000 | 20 K to 41 K (+105.00 %) |
Jan 13 2015 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | P | 3.00 | 10,000 | 29,984 | 307,126 | 297.1 K to 307.1 K (+3.37 %) |
Jan 08 2015 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | P | 2.80 | 50,000 | 139,750 | 3,970,918 | 3.9 M to 4 M (+1.28 %) |
Nov 17 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.00 | 26,667 | 0 | 1,151,054 | |
Nov 17 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.00 | 26,667 | 0 | 1,124,387 | |
Nov 17 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | A | 0.00 | 26,666 | 0 | 1,097,720 | |
Oct 20 2014 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Option Exercise | M | 0.90 | 125,000 | 112,500 | 297,500 | |
Oct 20 2014 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Payment of Exercise | F | 0.00 | 45,363 | 0 | 96,931 | 142.3 K to 96.9 K (-31.88 %) |
Oct 20 2014 | CPRX | CATALYST PHARMACEU ... | Winship M Douglas | VP, Regulatory Oper ... | Buy | M | 0.90 | 125,000 | 112,500 | 142,294 | 17.3 K to 142.3 K (+722.79 %) |
Oct 20 2014 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Option Exercise | M | 0.90 | 30,000 | 27,000 | 160,000 | |
Oct 20 2014 | CPRX | CATALYST PHARMACEU ... | Tierney David S | Director | Buy | M | 0.90 | 30,000 | 27,000 | 243,401 | 213.4 K to 243.4 K (+14.06 %) |
Oct 07 2014 | CPRX | CATALYST PHARMACEU ... | MUTH DAVID D | Exec. V.P., Corp. D ... | Buy | P | 2.65 | 10,000 | 26,500 | 20,000 | 10 K to 20 K (+100.00 %) |
Oct 06 2014 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Option Exercise | M | 0.90 | 30,000 | 27,000 | 639,804 | |
Oct 06 2014 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Payment of Exercise | F | 0.00 | 9,964 | 0 | 1,324,170 | 1.3 M to 1.3 M (-0.75 %) |
Oct 06 2014 | CPRX | CATALYST PHARMACEU ... | HUCKEL HUBERT E MD | Director | Buy | M | 0.90 | 30,000 | 27,000 | 1,334,134 | 1.3 M to 1.3 M (+2.30 %) |
Oct 06 2014 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Option Exercise | M | 0.90 | 30,000 | 27,000 | 150,000 | |
Oct 06 2014 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Payment of Exercise | F | 0.00 | 9,964 | 0 | 131,672 | 141.6 K to 131.7 K (-7.03 %) |
Oct 06 2014 | CPRX | CATALYST PHARMACEU ... | COELHO PHILIP H | Director | Buy | M | 0.90 | 20,036 | 18,032 | 141,636 | 121.6 K to 141.6 K (+16.48 %) |
Oct 03 2014 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Option Exercise | M | 0.90 | 175,000 | 157,500 | 535,000 | |
Oct 03 2014 | CPRX | CATALYST PHARMACEU ... | Miller Steve | Chief Operating Off ... | Buy | M | 0.90 | 175,000 | 157,500 | 389,754 | 214.8 K to 389.8 K (+81.49 %) |
Oct 03 2014 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Option Exercise | M | 0.90 | 105,000 | 94,500 | 191,250 | |
Oct 03 2014 | CPRX | CATALYST PHARMACEU ... | O'Keeffe Charles B | Director | Buy | M | 0.90 | 105,000 | 94,500 | 297,126 | 192.1 K to 297.1 K (+54.65 %) |
Oct 03 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Option Exercise | M | 0.90 | 150,000 | 135,000 | 1,231,054 | |
Oct 03 2014 | CPRX | CATALYST PHARMACEU ... | MCENANY PATRICK J | President and CEO | Buy | M | 0.90 | 150,000 | 135,000 | 3,920,918 | 3.8 M to 3.9 M (+3.98 %) |
Oct 03 2014 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Option Exercise | M | 0.90 | 90,000 | 81,000 | 500,000 | |
Oct 03 2014 | CPRX | CATALYST PHARMACEU ... | GRANDE ALICIA | VP, Treasurer and C ... | Buy | M | 0.90 | 90,000 | 81,000 | 156,346 | 66.3 K to 156.3 K (+135.65 %) |